Agile Therapeutics Non-GAAP EPS of -1.47 beats by 0.37, revenue of 6.66M beats by 0.31M
AGRXDelisted Stock | USD 2.94 0.08 2.65% |
Slightly above 62% of Agile Thrpe's investor base is looking to short. The analysis of current outlook of investing in Agile Thrpe suggests that many traders are alarmed regarding Agile Thrpe's prospects. Agile Thrpe's investing sentiment can be driven by a variety of factors including economic data, Agile Thrpe's earnings reports, geopolitical events, and overall market trends.
Agile |
Agile Therapeutics financial results for Q3 show a strong performance, surpassing expectations with a higher-than-anticipated EPS and revenue growth.
Read at seekingalpha.com
Agile Thrpe Fundamental Analysis
We analyze Agile Thrpe's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Agile Thrpe using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Agile Thrpe based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Agile Thrpe is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Agile Thrpe Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Agile Thrpe stock to make a market-neutral strategy. Peer analysis of Agile Thrpe could also be used in its relative valuation, which is a method of valuing Agile Thrpe by comparing valuation metrics with similar companies.
Peers
Agile Thrpe Related Equities
LFCR | Lifecore Biomedical | 4.73 | ||||
CYTH | Cyclo Therapeutics | 4.29 | ||||
PTPI | Petros Pharmaceuticals | 3.85 | ||||
AQST | Aquestive Therapeutics | 1.11 | ||||
AMRX | Amneal Pharmaceuticals, | 0.84 | ||||
TKNO | Alpha Teknova | 0.69 | ||||
SHPH | Shuttle Pharmaceuticals | 1.02 | ||||
CPIX | Cumberland Pharmaceuticals | 1.85 | ||||
ASRT | Assertio Therapeutics | 3.09 | ||||
EVOK | Evoke Pharma | 3.78 | ||||
PRFX | Painreform | 7.19 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Agile Stock
If you are still planning to invest in Agile Thrpe check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Agile Thrpe's history and understand the potential risks before investing.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Global Correlations Find global opportunities by holding instruments from different markets |